查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
体脂减少的全球市场:市场规模 - 各手术，各服务供应商，性别，各地区展望，竞争策略，各市场区隔预测(～2030年)
市场调查报告书
商品编码
1159595

体脂减少的全球市场:市场规模 - 各手术，各服务供应商，性别，各地区展望，竞争策略，各市场区隔预测(～2030年)

Body Fat Reduction Market Size - By Procedure, By Service Provider, By Gender- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 256 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球体脂减少的市场规模，预计至2030年达到161亿2,000万美元，以8.2％的年复合成长率成长。

由于不良的饮食习惯，对由于生活方式的变化，运动不足，久坐的生活方式带来的肥胖案例增加，及肥胖的政府政策和计划，手术的采用，促进体脂减少市场。由于更廉价，侵入性、不适感低，结果的风险也低，微侵袭性治疗法，预计独占市场。

本报告提供全球体脂减少市场相关调查，市场动态，市场变数及预测，各手术、服务供应商、性别、地区的市场分析，企业简介等相关资讯。

目录

第1章 简介

  • 调查范围
  • 市场区隔分析

第2章 调查手法

  • 调查资料来源
  • 市场规模的估计
  • 资料的三角测量

第3章 摘要整理

第4章 市场动态

  • 促进因素，阻碍因素，机会，课题的分析
    • 促进因素
    • 阻碍因素
    • 机会
    • 课题
  • 全球体脂减少市场上COVID-19的影响

第5章 市场变数及预测

  • SWOT分析
    • 优势
    • 弱点
    • 机会
    • 威胁
  • PESTEL分析
    • 政治形势
    • 经济形势
    • 社会形势
    • 技术形势
    • 环境形势
    • 法律上的形势
  • 波特的五力分析
    • 供给企业谈判力
    • 买方议价能力
    • 替代品的威胁
    • 新加入厂商的威胁
    • 竞争企业间的敌对关係
  • 热图分析

第6章 全球体脂减少市场:各手术，2019年～2030年(100万美元)

  • 外科
    • 腹部形成术
    • 抽脂
  • 非外科
    • 超音波
    • 冻结脂解法
    • 其他

第7章 全球体脂减少市场:各服务供应商，2019年～2030年(100万美元)

  • 医院
  • 诊所
  • 医疗SPA
  • 其他

第8章 全球体脂减少市场:各性别，2019年～2030年(100万美元)

  • 女性
  • 男性

第9章 全球体脂减少市场:各地区，2019年～2030年(100万美元)

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的亚太地区
  • 南美
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中东、非洲
    • 沙乌地阿拉伯王国
    • 阿拉伯联合大公国
    • 其他的中东、非洲

第10章 企业简介

  • AbbVie Inc. (Allergan Inc.)
    • 企业概要
    • 财务预测
    • 产品概要
    • 最近的开发
  • Apollo Hospitals Enterprise Limited
  • Bausch Health Companies Inc.
  • Cutera, Inc.
  • Candela Medical
  • Cynosure, Llc
  • Lumenis Ltd
  • Sciton Inc.
  • Sisram Medical Ltd
  • VLCC Health Care Limited
简介目录
Product Code: HLCA2215

Global Body Fat Reduction Market Overview:

According to SPER Market Research, the Global Body Fat Reduction Market is estimated to reach USD 16.12 billion by 2030 with a CAGR of 8.2%.

Body fat reduction is the term used to describe a reduction in total body weight brought on by the loss of fluid, adipose tissue, or lean mass, including bone mineral deposits, muscle, tendon, and other connective tissue. It is the process of reducing extra body fat with a variety of goals in mind, such as improving the shape and appearance of the body. Adipose tissue, or body fat, has particular roles in the metabolism and endocrine system. The removal of extra adipose tissue or fats from the body via surgical or non-surgical means is a common practice in cosmetic surgery. there are many treatments on the market, including abdominoplasty (tummy tuck), laser lipolysis, cryolipolysis, liposuction, ultrasound, red light therapy, and injectable therapy.

Obesity is a growing public health issue in both industrialised and emerging nations, largely due to the population's unhealthy, stressful lifestyle. In addition to genetic, physiological, and environmental factors, eating habits, exercise preferences, and physical activity levels all contribute to obesity. People use surgical and non-surgical methods to achieve their goal of losing body fat. thus, it is anticipated that the body fat reduction market will grow due to the rise in obesity cases brought on by bad eating habits, lifestyle changes, lack of exercise, and adoption of a sedentary lifestyle, as well as favourable government policies and programmes for obesity that are encouraging the adoption of body fat reduction procedures.

Due to its emphasis on minimum blood loss, shorter patient stays, safety, and convenience of use, minimally invasive therapy approaches for body fat removal are becoming more and more popular. Because they are more affordable, less intrusive, and uncomfortable, and have a lower risk of consequences, minimally invasive procedures are predicted to dominate the market. The procedure of enhancing the appearance of the face and body is known as aesthetic plastic surgery (sometimes referred to as cosmetic surgery). Increased demand for surgical and non-surgical body contouring or body shaping procedures also contributes to the market's expansion.

In addition, surgeries to lose weight or alter the body after childbirth are becoming more popular. Young people and women are becoming more conscious of their physical appearance and fitness levels in order to achieve body slimming. Therefore, it is anticipated that these factors will significantly drive the expansion of the body fat reduction market over the forecast period.

The global fat reduction market is segmented n the basis of procedure, service provider and gender. On the basis of procedure, the surgical segment dominated the market is expected to dominate the market during forecast period due to rising demand for weight loss and obesity treatments and aesthetic improvement operations. On the basis of service provider, hospitals and clinics subsegment is expected to dominate during the forecast period. On the basis of gender, the female subsegment will dominate the market due to elf-conscious about having attractive and artistic appearances. However, the high cost of these procedures and some side effects following therapy are anticipated to hinder market expansion.

Impact of COVID-19 on the Global Body Fat Reduction Market

The COVID-19 pandemic has had a significant negative influence on the expansion of the body fat reduction sector since it has temporarily halted some medical treatments and suspended some aesthetic treatment procedures. However, a rise in weight gain difficulties was caused by the temporary closure of fitness centres and the adoption of the work from home (WFH) culture, which is predicted to spur market expansion over the course of the projection period.

Scope of the report

Report Metric Details

Market size available for years 2019-2030

Base year considered 2021

Forecast period 2022-2030

Segments covered By Procedure, By Service Provider, By Gender

Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Covered AbbVie Inc. (Allergan Inc.), Apollo Hospitals Enterprise Limited, Bausch Health Companies Inc., Cutera, Inc., Candela Medical, Cynosure, Llc, Lumenis Ltd, Sciton Inc., Sisram Medical Ltd, Vlcc Health Care Limited.

Global Body Fat Reduction Market Segmentation:

By Procedure: Based on the Procedure, Global Body Fat Reduction Market is segmented as; Surgical (Abdominoplasty, Liposuction), Non-Surgical (Ultrasound, Cryolipolysis, Others).

By Service Provider: Based on the Service Provider, Global Body Fat Reduction Market is segmented as; Hospitals, Clinics, Medical Spas, Others.

By Gender: Based on the Gender, Global Body Fat Reduction Market is segmented as; Females and Males.

By Region: North America is expected to maintain its leadership position during the projection period. Due to the rising frequency of obesity cases, the existence of important players, an increase in healthcare spending, technological improvements, and an increase in regional government efforts.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Body Fat Reduction Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Body Fat Reduction Market, By Procedure, 2019-2030 (USD Million)

  • 6.1 Surgical
    • 6.1.1 Abdominoplasty
    • 6.1.2 Liposuction
  • 6.2 Non-Surgical
    • 6.2.1 Ultrasound
    • 6.2.2 Cryolipolysis
    • 6.2.3 Others

7. Global Body Fat Reduction Market, By Service Provider, 2019-2030 (USD Million)

  • 7.1 Hospitals
  • 7.2 Clinics
  • 7.3 Medical Spas
  • 7.4 Others

8. Global Body Fat Reduction Market, By Gender, 2019-2030 (USD Million)

  • 8.1 Females
  • 8.2 Males

9 Global Body Fat Reduction Market, By Region, 2019-2030 (USD Million)

  • 9.1 North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2 Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4 South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5 Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10 Company Profiles

  • 10.1 AbbVie Inc. (Allergan Inc.)
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2 Apollo Hospitals Enterprise Limited
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3 Bausch Health Companies Inc.
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4 Cutera, Inc.
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5 Candela Medical
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6 Cynosure, Llc
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7 Lumenis Ltd
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8 Sciton Inc.
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9 Sisram Medical Ltd
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. VLCC Health Care Limited
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments